Trial Profile
Facilitation of Extinction Retention and Reconsolidation Blockade by IV Allopregnanolone in PTSD
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Dec 2023
Price :
$35
*
At a glance
- Drugs Allopregnanolone (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 23 May 2022 Planned End Date changed from 1 Mar 2025 to 1 Dec 2024.
- 23 May 2022 Planned primary completion date changed from 1 Mar 2025 to 1 Dec 2024.
- 24 Feb 2022 Planned initiation date changed from 1 Feb 2022 to 1 Mar 2022.